SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-070209
Filing Date
2013-09-16
Accepted
2013-09-16 16:53:36
Documents
3
Period of Report
2013-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-20765_18k.htm 8-K 37155
2 EX-3.1 a13-20765_1ex3d1.htm EX-3.1 121267
3 EX-10.1 a13-20765_1ex10d1.htm EX-10.1 353483
  Complete submission text file 0001104659-13-070209.txt   513239
Mailing Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302 (201) 333-8819
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 131099328
SIC: 2834 Pharmaceutical Preparations